Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Sep 13;91(19):9190-4.
doi: 10.1073/pnas.91.19.9190.

Mapping of the C5a receptor signal transduction network in human neutrophils

Affiliations

Mapping of the C5a receptor signal transduction network in human neutrophils

A M Buhl et al. Proc Natl Acad Sci U S A. .

Abstract

Human neutrophils respond to chemoattractants, resulting in their accumulation at an inflammatory site. Chemoattractants such as the C5a peptide, derived from the C5 complement factor, bind to inhibitory guanine nucleotide binding protein (Gi)-coupled seven membrane-spanning receptors expressed in neutrophils. C5a receptor activation results in the Gi-dependent activation of the mitogen-activated protein (MAP) kinase pathway in human neutrophils. C5a receptor ligation activates both B-Raf and Raf-1, with B-Raf activation overlapping but temporally distinct from that of Raf-1. B-Raf and Raf-1 both efficiently phosphorylate MAP kinase kinase (MEK-1). C5a also stimulates guanine nucleotide exchange and activation of Ras. Ras and Raf activation in response to C5a involves protein kinase C-dependent and -independent pathways. Activation of both Raf-1 and B-Raf was inhibited by protein kinase A stimulation, consistent with the inhibitory effects of increased cAMP levels on neutrophil function. The findings define a functional signal transduction pathway linking the neutrophil C5a chemoattractant receptor to the regulation of Ras, B-Raf, Raf-1, and MAP kinase.

PubMed Disclaimer

References

    1. Int Arch Allergy Immunol. 1992;97(3):194-9 - PubMed
    1. J Biol Chem. 1992 Apr 25;267(12):7987-90 - PubMed
    1. J Immunol. 1992 Jul 15;149(2):609-14 - PubMed
    1. Nature. 1992 Jul 30;358(6385):417-21 - PubMed
    1. Cell. 1992 Aug 7;70(3):389-99 - PubMed

Publication types

MeSH terms

Substances